SCHEMBL39111

SCHEMBL39111

CC(C)Cc1cccc(C(=O)O)c1O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.66
GABRB2 P47870 2/20 0.66
HMGB1 P09429 1/20 0.57
ALDH1A1 P00352 4/20 0.52
HPGD P15428 2/20 0.52
KDM4E B2RXH2 2/20 0.52
HSD17B10 Q99714 1/20 0.52
ALB P02768 1/20 0.47
MMP2 P08253 1/20 0.47
HNF4A P41235 1/20 0.44
ELANE P08246 2/20 0.43
CTSG P08311 1/20 0.43
AKR1C2 P52895 1/20 0.42
AKR1C1 Q04828 1/20 0.42
CLCN2 P51788 1/20 0.41
KMT2A Q03164 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
FOLH1 Q04609 1/20 0.41
LMNA P02545 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL21836081 0.98 GABRA1 (0.63) GABRA1GABRB2HMGB1ALDH1A1HPGD
Bicarbonate SCHEMBL236892 0.98 GABRA1 (0.63) GABRA1GABRB2HMGB1ALDH1A1HPGD
SCHEMBL2165949 0.87 GABRA1 (0.50) GABRA1GABRB2HMGB1ALDH1A1HPGD
SCHEMBL1552387 0.85 HMGB1 (0.53) GABRA1GABRB2HMGB1ALDH1A1HPGD
SCHEMBL23642840 0.83 HMGB1 (0.51) GABRA1GABRB2HMGB1ALDH1A1HPGD
SCHEMBL28460329 0.83 GABRA1 (0.58) GABRA1GABRB2HMGB1KDM4EHSD17B10
SCHEMBL23642833 0.83 HMGB1 (0.51) GABRA1GABRB2HMGB1ALDH1A1HPGD
SCHEMBL157592 0.83 FOLH1 (0.53) GABRA1GABRB2HMGB1ALDH1A1HPGD
SCHEMBL10782179 0.83 HMGB1 (0.54) GABRA1GABRB2HMGB1ALDH1A1HPGD
SCHEMBL5172249 0.83 HMGB1 (0.63) GABRA1GABRB2HMGB1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400784-A1 Method for Screening Solvent for Extracting Polyvinyl Chloride, Method for Recycling Waste, Recycled Polyvinyl Chloride, and Composition LG CHEM, LTD. (KR) 2024-12-05 US claimed
US-20240392094-A1 Method for Screening Solvent for Polyvinyl Chloride Extraction, Recycling Method for Waste Material, and Recycled Polyvinyl Chloride and Composition LG CHEM, LTD. (KR) 2024-11-28 US claimed
WO-2023033601-A1 METHOD FOR SCREENING SOLVENT FOR POLYVINYL CHLORIDE EXTRACTION, RECYCLING METHOD FOR WASTE MATERIAL, AND RECYCLED POLYVINYL CHLORIDE AND COMPOSITION 주식회사 엘지화학 2023-03-09 WO claimed
WO-2023033605-A1 METHOD FOR SCREENING SOLVENT FOR EXTRACTING POLYVINYL CHLORIDE, METHOD FOR RECYCLING WASTE, RECYCLED POLYVINYL CHLORIDE, AND COMPOSITION 주식회사 엘지화학 2023-03-09 WO claimed
EP-3452128-B1 MODIFIED BIODEGRADABLE AND MEDICAL POLYMER DEVICES AND A METHOD FOR PREPARING THE SAME BEIJING ADVANCED MEDICAL TECH LTD INC (CN) 2021-10-27 EP claimed
EP-2178491-B1 MIXTURES COMPRISING BENZOTRIAZOLES AND MEROCYANINES BASF SE (DE) 2017-03-22 EP claimed
US-20160346181-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2016-12-01 US claimed
WO-2016005149-A1 LOW-ODOR POLYURETHANE SYSTEMS EVONIK DEGUSSA GMBH (DE) 2016-01-14 WO claimed
EP-1968531-B1 TOPICAL COMPOSITIONS FOR REDUCING SKIN IRRITATION GIVAUDAN SA (CH) 2014-12-31 EP claimed
WO-2014187576-A1 DEODORIZING ACTIVE INGREDIENT COMBINATION HENKEL AG & CO. KGAA (DE) 2014-11-27 WO claimed
EP-2020225-B1 Fragrance composition KAO CORP (JP) 2014-10-08 EP claimed
US-20120184513-A1 Organic Compounds GIVAUDAN SA (CH) 2012-07-19 US claimed
EP-2211829-B1 IMPROVEMENT OF THE FRAGRANCE EFFECT OF PERFUME ESTERS HENKEL AG & CO KGAA (DE) 2011-04-27 EP claimed
EP-2211829-A1 IMPROVEMENT OF THE FRAGRANCE EFFECT OF PERFUME ESTERS Henkel AG & Co. KGaA (DE) 2010-08-04 EP claimed
US-20100063011-A1 Organic compounds GIVAUDAN SA (CH) 2010-03-11 US claimed
WO-2009059858-A1 IMPROVEMENT OF THE FRAGRANCE EFFECT OF PERFUME ESTERS HENKEL AG & CO. KGAA (DE) 2009-05-14 WO claimed
EP-1968531-A2 TOPICAL COMPOSITIONS FOR REDUCING SKIN IRRITATION Givaudan SA (CH) 2008-09-17 EP claimed
WO-2007030961-A2 TOPICAL COMPOSITIONS FOR REDUCING SKIN IRRITATION GIVAUDAN SA (CH) 2007-03-22 WO claimed
WO-2025228904-A1 LAYER STRUCTURE WITH AT LEAST TWO LAYERS HAVING DIFFERENT ENGRAVINGS COVESTRO DEUTSCHLAND AG (DE) 2025-11-06 WO disclosed
EP-0045861-A2 Unsaturated compounds, process for their preparation, their use as perfumes and the perfumed compositions containing them L. GIVAUDAN & CIE Société Anonyme (CH) 1982-02-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063011-A1 Organic compounds CYP1A1, CYP1B1, OXER1 GABRA1 3492/4885GABRB2 3369/4885HMGB1 299/4885
US-20120184513-A1 Organic Compounds CYP1A1, CYP1B1, OXER1 GABRA1 3492/4885GABRB2 3369/4885HMGB1 299/4885
US-20160346181-A1 ORGANIC COMPOUNDS CYP1A1, CYP1B1, OXER1 GABRA1 3492/4885GABRB2 3369/4885HMGB1 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.